Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Novartis
Novartis
Page 2 of 4
Leadership
Novartis CEO: It’s Time to “Pivot Towards Transformational Innovation”
By
Susie Gharib
March 20, 2019
Net Drug Prices Are Falling, Even as List Prices Increase
By
Renae Reints
January 30, 2019
Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal
By
Bloomberg
December 18, 2018
Health
Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By
Sy Mukherjee
October 11, 2018
Health
Drug Giant Novartis Is Temporarily Backing Off Price Increases Following Trump Pressure
By
Sy Mukherjee
July 19, 2018
Health
Novartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback
By
Sy Mukherjee
June 29, 2018
Health
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By
David Meyer
May 18, 2018
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By
Sy Mukherjee
May 17, 2018
Leadership
Top Novartis Lawyer Exits Over the $1.2 Million It Paid to Trump Lawyer Michael Cohen
By
David Meyer
May 16, 2018
Health
That $1.2 Million Payment to Trump’s Lawyer Wasn’t Even a Drop in the Bucket for Novartis
By
Sy Mukherjee
May 10, 2018
Health
Novartis Put Money In Michael Cohen’s Cookie Jar. Did It Get Any Cookies In Return?
By
Clifton Leaf
May 9, 2018
Health
Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By
Sy Mukherjee
January 22, 2018
Health
The First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By
Sy Mukherjee
December 19, 2017
Health
Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By
Sy Mukherjee
November 16, 2017
Health
We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By
Sy Mukherjee
November 2, 2017
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore
AI
'Robots are going to be amongst us': Qualcomm exec says buckle up for the next 5 years. Your car is going to be the...
By
Nino Paoli